The hazard ratio, which was adjusted in the multivariate Cox regression model for tumor progression, is lower in patients with a higher increase of anti-ENO1 Ab (P = 0.011), adenocarcinoma subtype (P = 0.017) and a small tumor volume (P = 0.017) (Table 3). This evidence concerns the gene ENO1 and neoplasm.